Measurement of blood components fluctuation after eating sugarless confectionery (study B).
- Conditions
- Healthy volunteers
- Registration Number
- JPRN-UMIN000051076
- Lead Sponsor
- EP Mediate Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 36
Not provided
(1) Subjects who are judged as unsuitable for the study based on the results of clinical laboratory test or cardiopulmonary function. (2)Subjects who routinely use medicines and health foods related to blood glucose level and glucose metabolism. (3) Subjects who have possibilities for emerging allergy related to the study. (4) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire. (5) Subjects who have under treatment. (6) Subjects who have a history of pancreatic disease, endocrine disease (including diseases related to the thyroid gland), liver disease, gastric resection and other diseases that may cause diabetes / glucose metabolism disorders. (7) Subjects who have a disease requiring continuous medication, or serious medical history who needed medication. (8) Subjects whose measured value and clinical laboratory tests on preliminary examination are significantly out of the standard values. (9) Subjects who have a habit of skipping food on a daily basis, or those who have an extremely irregular diet. (10) Subjects who are engaged in day / night shift work, midnight work, or irregular life habits. (11) Subjects who have been diagnosed with insomnia or sleep apnea, or who have extremely irregular sleep habits. (12) Subjects who plan to travel abroad during the study, or those who plan to go on a domestic business trip, domestic trip, or return to their hometown for the three days before the examination date of intake period I or intake period II. (13) Subjects who have participated in other clinical study within the last one month prior to the current study or have participated in other clinical studies. (14) Subjects who intend to become pregnant or lactating. (15) Subjects who have collected more than 200 mL of blood within 1 month or donated more than 400 mL of blood within 3 months from the date of consent acquisition. (16) Others who are judged by the investigator to be inappropriate as subjects.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood glucose level, blood glucose level IAUC
- Secondary Outcome Measures
Name Time Method Insulin level, Insulin level IAUC